# Rani Therapeutics (RANI) — Earnings

RANI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rani/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Dec 31, 2025 |
| EPS actual | −$0.07 |
| EPS estimate | −$0.05 |
| EPS surprise | −47.37% |
| Revenue surprise | −70.78% |
| Revenue | $1.5M |
| Revenue estimate | $5.0M |
| Reported | Mar 26, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1856725/000119312526126240/rani-20260326.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/format/d6fa1b8b-cc22-548b-24f3-ba1532b79f21.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Mar 26, 2026 | −$0.05 | −$0.07 | -47.37% | $5.0M | $1.5M |
| Q2 2025 | Aug 7, 2025 | −$0.29 | −$0.18 | 36.84% | — | — |
| Q1 2025 | May 13, 2025 | −$0.28 | −$0.22 | 21.43% | — | $172,000.00 |
| Q4 2024 | Mar 31, 2025 | −$0.27 | −$0.27 | -0.45% | — | $1.0M |
| Q3 2024 | Nov 14, 2024 | −$0.29 | −$0.24 | 17.24% | — | — |
| Q2 2024 | Aug 6, 2024 | −$0.34 | −$0.26 | 22.43% | — | — |
| Q1 2024 | May 6, 2024 | −$0.28 | −$0.29 | -4.32% | — | — |
| Q4 2023 | Mar 20, 2024 | −$0.38 | −$0.27 | 28.95% | — | — |
| Q3 2023 | Nov 8, 2023 | −$0.43 | −$0.36 | 15.49% | — | — |
| Q2 2023 | Aug 11, 2023 | −$0.42 | −$0.37 | 12.82% | — | — |
| Q1 2023 | May 10, 2023 | −$0.47 | −$0.33 | 29.34% | — | — |
| Q4 2022 | Mar 22, 2023 | −$0.40 | −$0.35 | 12.72% | $108,333.00 | — |
| Q3 2022 | Nov 10, 2022 | −$0.52 | −$0.33 | 37.13% | $130,000.00 | — |
| Q2 2022 | Aug 10, 2022 | −$0.52 | −$0.31 | 39.92% | $130,000.00 | — |
| Q1 2022 | May 11, 2022 | −$0.66 | −$0.29 | 56.06% | $325,000.00 | — |
| Q4 2021 | Mar 29, 2022 | −$0.50 | −$0.27 | 45.45% | $162,500.00 | — |
| Q3 2021 | Nov 16, 2021 | −$0.18 | −$0.16 | 11.11% | $630,000.00 | — |
| Q2 2021 | Sep 13, 2021 | −$0.18 | −$0.12 | 31.82% | $490,000.00 | $2.0M |

## Frequently Asked Questions

### When did Rani Therapeutics (RANI) last report earnings?

Rani Therapeutics last reported on Mar 26, 2026, covering fiscal Q4 2025.

### Did RANI beat earnings estimates?

No. Rani Therapeutics reported EPS of −$0.07 for Q4 2025 against a −$0.05 estimate — a 47.37% miss.

### How much revenue did RANI report last quarter?

Rani Therapeutics reported $1.5M in revenue for Q4 2025, against a consensus estimate of $5.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).